- Seebri Neohaler is an anticholinergic indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema
SEEBRITMNEOHALERR (glycopyrrolate) inhalation powder
NATL
Drug | Dosing Regimen | Dose Limit/ Maximum Dose |
---|---|---|
Advair DiskusR (fluticasone propionate/salmeterol) | COPD | COPD: |
SymbicortR (budesonide/formoterol) | COPD | COPD: |
DuleraR (mometasone/formoterol) | Asthma | Asthma: |
AtroventTM HFA and 0.02% Solution for Inhalation (ipratropium bromide) | COPD | HFA: 3 puffs 4 times per day |
SpirivaR (tiotropium bromide) | COPD | 1 capsule per day |
TudorzaTM PressairTM (aclidinium bromide) | COPD | 1 puff twice daily |
SereventR Diskus (salmeterol xinafoate) | COPD | COPD: |
ForadilR AerolizerR, PerforomistR (formoterol fumarate) | COPD | Foradil: 1 capsule every 12 hours |
Combivent RespimatR and DuonebR Inhalation Solution (albuterol sulfate/ ipratropium bromide) | COPD | Combivent Respimat: 6 inhalations per day |
ArcaptaTM NeohalerTM (indacaterol) | COPD | 75 mcg once daily |
BrovanaR (arformoterol) | COPD | 15 mcg twice daily |
BreoR ElliptaR (fluticasone furoate/vilanterol) | COPD | 100 mcg/25 mcg daily |
Incruse ElliptaR (umeclidinium inhalation powder) | COPD | 62.5 mcg daily |
Drug | Dosing Regimen | Authorization Limit |
---|---|---|
Seebri Neohaler | COPD | Length of Benefit |
Inhalation powder: contains Seebri (glycopyrrolate (15.6 mcg) inhalation powder) orange transparent capsules packaged in aluminium blister cards, one Neohaler device. Unit Dose (blister pack), Box of 60 (10 blister cards with 6 orange transparent capsules each). The neohaler device consists of a white protective cap and a base with mouthpiece, capsule chamber and 2 orange push buttons.
1. Seebri Neohaler [Prescribing Information]. East Hanover, NJ: Novartis; October 2015.
2. MicromedexR Healthcare Series [Internet Database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Accessed November 15, 2015.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. Available at http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Feb18.pdf. Accessed November 11, 2015.